首页> 外文OA文献 >Development of an Enzyme-Linked Immunosorbent Assay for Serotyping Ureaplasma urealyticum Strains Using Monoclonal Antibodies
【2h】

Development of an Enzyme-Linked Immunosorbent Assay for Serotyping Ureaplasma urealyticum Strains Using Monoclonal Antibodies

机译:使用单克隆抗体对解脲脲原体菌株进行酶分型的酶联免疫吸附测定方法的开发

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ureaplasma urealyticum comprises 14 serotypes. The existing serotyping methods all use polyclonal antibodies. These methods are time-consuming and labor-intensive, and they cannot always be performed on primary isolates; in addition, the results are difficult to interpret. We developed a new enzyme-linked immunosorbent assay (ELISA) method using serotype-specific monoclonal antibodies (MAbs) to enable the serotyping of U. urealyticum isolates from primary broth cultures. Each of the 14 serotype reference strains was tested against 14 selected MAbs. Homologous reactions were very strong, while heterologous reactions were negligible. Three cross-reactions were observed: MAb 5 cross-reacted with serotype 2, MAb 14 cross-reacted with serotype 3, and MAb 8 cross-reacted with serotype 13. Despite the cross-reactions observed, all the serotype reference strains of U. urealyticum could be identified and differentiated using a combination of MAbs. Reproducibility was analyzed with a fractionated antigenic preparation and with several freshly prepared antigens of the same strain. No significant interrun variation was found with the fractionated antigen, but significant variations in optical density (OD) values were found when freshly prepared antigens were tested. However, the variation in OD values did not influence the overall interpretation of the ELISA: reactions with homologous MAbs were always prominent compared to those of the negative controls. This newly developed ELISA using MAbs seems promising for serotyping of U. urealyticum clinical isolates.
机译:解脲脲原体包括14种血清型。现有的血清分型方法均使用多克隆抗体。这些方法既费时又费力,而且不能总是在主要分离株上进行。另外,结果难以解释。我们开发了一种新的酶联免疫吸附测定(ELISA)方法,使用血清型特异性单克隆抗体(MAbs)使来自原液培养物的解脲支原体分离株进行血清分型。测试了14种血清型参考菌株中的每一种是否针对14种选择的单克隆抗体。同源反应非常强,而异源反应可以忽略不计。观察到三个交叉反应:MAb 5与血清型2发生交叉反应,MAb 14与血清型3发生交叉反应,MAb 8与血清型13发生交叉反应。尽管观察到交叉反应,但所有U的血清型参考菌株都存在。解脲支原体可以通过结合单克隆抗体来鉴定和区分。用分级抗原制剂和同一菌株的几种新鲜制备的抗原分析可重复性。分馏的抗原没有发现显着的运行间变化,但是当测试新鲜制备的抗原时,发现了光密度(OD)值的显着变化。但是,OD值的变化不会影响ELISA的整体解释:与阴性对照相比,与同源MAb的反应始终很突出。这种新近开发的使用单抗的ELISA有望用于解脲脲原体临床分离株的血清分型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号